Skip to main content
ST

StemInov

Vandoeuvre-lès-nancy, France
Last funding
$12.5M
Series ASep 2025

StemInov develops stem cell therapies for inflammatory diseases, focusing on septic shock and ARDS.

Backed byAlsace Business AngelsFinovam GestionAngels SantéLes Business Angels des Grandes √âcolesILP - Sadepar

About StemInov

How much funding has StemInov raised?

StemInov has raised $12.5M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are StemInov's investors?

StemInov's investors include Alsace Business Angels, Finovam Gestion, Angels Santé, Les Business Angels des Grandes √âcoles, ILP - Sadepar.

Where is StemInov headquartered?

StemInov is headquartered in Vandoeuvre-lès-nancy, France.

What does StemInov do?

StemInov develops stem cell therapies for inflammatory diseases, focusing on septic shock and ARDS.

What stage is StemInov at?

StemInov is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"StemInov — Funding & Investors." VCBacked, September 25, 2025, https://www.vcbacked.co/company/steminov. Accessed November 21, 2026.
APA
VCBacked. (2025). StemInov — Funding & Investors. Retrieved November 21, 2026, from https://www.vcbacked.co/company/steminov
Wikipedia (cite web)
{{cite web |title=StemInov — Funding & Investors |url=https://www.vcbacked.co/company/steminov |website=VCBacked |access-date=November 21, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at StemInov? Request a listing update

Founder contacts
m***@steminov.com
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →